Navigation Links
Mindray Medical International Announces Second Quarter 2008 Results
Date:9/3/2008

56.7 million and US$23.1 million, respectively.

As of July 31, 2008 the Company had 5,300 employees compared to 3,705 employees on December 31, 2007.

Business Outlook for Full Year 2008

In May 2008, Mindray completed its acquisition of the patient monitoring business of Datascope Corporation (Nasdaq: DSCP) for approximately $209 million in cash (the the "transaction"). Upon completion of this transaction, Mindray became the third-largest player in the global patient monitoring device industry furthering Mindray's goal of becoming a leading provider of high-quality medical devices to markets worldwide. After closing of the transaction, the Company maintains its full-year 2008 net revenue guidance to be in the range of US$560 million to US$580 million, including the consolidation of Datascope's patient monitoring business starting from May 1, 2008.

The updated full-year 2008 non-GAAP (excluding share-based compensation expenses and amortization of intangible assets resulting from acquisitions) net income guidance will be in the range of US$132 million to US$135 million, taking into consideration a 15% effective income tax rate after certain government tax incentives and rebates.

Non-GAAP EPS is expected to be in the range of US$1.16 to US$1.18 per fully diluted share based on an estimated average diluted share count of 114 million for the year. The Company expects DPM acquisition to yield a neutral impact to its 2008 non-GAAP EPS.

In accordance with SFAS No. 123R, the Company estimates total share-based compensation expenses in 2008 will be approximately US$10 million based on employee share options that have been granted as of June 30, 2008. The Company expects approximately US$16.1 million in acquisition
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. Mindray Medical International Announces First Quarter 2008 Results
6. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
7. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
10. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
11. BioMS Medical announces its intention to renew a normal course issuer bid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MESA, Calif. , July 24, 2014  Now ... close to home. Rehealth Regenerative Therapies , located ... athletes and other physically active people a new health ... Regardless of age, countless patients suffer from ... sport activities, such as muscle tears, torn rotator cuff, ...
(Date:7/24/2014)... Quantum computers have yet to materialise. Yet, scientists ... making such computers faster. One such approach relies ... controlled by applying an electric field. A new ... coherently coupled quantum dots (TQDs) with electrical impulses ... for example, should TQDs be used as quantum ...
(Date:7/24/2014)... California (PRWEB) July 24, 2014 ... to advances in modeling lithium-ion battery storage capacity. ... benefit from a theoretical model created at ... University that predicts how carbon components will ... energy storage emphasizes the urgent need for higher-performance ...
(Date:7/24/2014)...  Neogen Corporation (Nasdaq: NEOG ) advised ... revenue from new rodenticide research are premature. In its ... July 22, 2014, Neogen,s CEO commented about several new ... "It was my intent Tuesday at our conference ... new type of rodenticide, but certainly not to give ...
Breaking Biology Technology:Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3Getting More Life out of Lithium-ion Batteries 2Neogen comments on SenesTech 2
... 2010 Sequenom, Inc. (Nasdaq: SQNM ... describing results from the R&D "locked-assay" verification study ... for Molecular Medicine. (Logo:   ... entitled "Noninvasive Detection of Fetal Trisomy 21 by ...
... 2010 Dr. Russell L. Chapman, former President of ... the research and teaching of algal related science in ... Chairman of its Science Advisory Board including university outreach, ... one of the preeminent scholars in the field of ...
... Dec. 15, 2010 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" or ... developer, manufacturer and distributor of probiotics products in China, ... Stockholders (the "Annual Meeting") will be held on Wednesday, ... Annual Meeting will be held at the Company,s executive ...
Cached Biology Technology:Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study 2Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study 3Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board 2Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board 3China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011 2China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011 3
(Date:7/24/2014)... animal species for food or commercial food sale, has ... the decline of many species of primates and other ... than half of the species being consumed are birds, ... not only the meat made available for sale but ... by hunters and brought to villages for consumption, we ...
(Date:7/24/2014)... where electric cars ply silent freeways, solar panels blanket ... the earth, from howling winds and from the blazing ... it is technically and economically feasible to convert California,s ... energy. Published in Energy , the plan shows ... supply in California that could create tens of thousands ...
(Date:7/24/2014)... of researchers has developed a new nanoscale agent for ... for assessing the function and properties of the GI ... and treatment of gut diseases. , Illnesses ... and inflammatory bowel disease all occur in the intestine ... with diseases such as diabetes and Parkinson,s. , ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4New imaging agent provides better picture of the gut 2
... The evolution of bird bills is related to climate according ... Brock University, Canada. By examining bill sizes of a ... found that birds with larger bills tend to be found ... smaller bills. The study led by Dr Matt Symonds ...
... , In what is believed to be the largest review of ... are more likely to clump faster than others, scientists at Johns ... which they say likely control that bodily function. "Our results ... produced from these genes, to develop tests that could help us ...
... The American Association for Cancer Research recognizes the first ... Act, which was signed into law by President Obama ... the Food and Drug Administration (FDA) to regulate the ... go into effect today include restrictions on youth access ...
Cached Biology News:Birds reduce their heating bills in cold climates 2Genetic septet in control of blood platelet clotting 2Genetic septet in control of blood platelet clotting 3AACR recognizes 1-year anniversary of tobacco law 2
... ESGRO Complete Derivation Kit is intended ... cells from delayed blastocysts in serum-free ... Clonal Grade ... Blastocyst Incubation Medium Trypsin Solution ...
streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
Template and primers for preparation of internal control spots...
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
Biology Products: